Antaros Medical

Antaros Medical is a Swedish company based in Mölndal that provides medical imaging solutions and clinical imaging trials to the pharmaceutical industry. Founded in 2014 by four entrepreneurs with extensive backgrounds in science and drug development, the company was built around the idea of using innovative imaging to give pharma companies critical, evidence-based decision support during clinical development. Its work sits at the intersection of ground-breaking medical imaging, deep knowledge of disease biology and profound experience in drug development. Antaros Medical describes itself as a strategic development partner to the pharmaceutical industry. Rather than offering imaging as a standalone technical service, it combines imaging capabilities with drug-development and disease-biology expertise so that it can advise on study design and deliver clinical imaging studies that address relevant biology. This mix of capabilities is presented as the company's distinguishing feature and the basis for solutions that few others can create. The company's scientific credibility is reflected in a body of over 800 peer-reviewed publications associated with its work. It operates globally in support of clinical trials, reporting more than 400 imaging sites worldwide and a team of over 100 employees, later described as more than 140 people across two continents. Its people are presented as the foundation of the business, with the company emphasizing a distinctive collaborative culture. Antaros Medical remains a privately held company. It continues to grow its team and its scientific presence, presenting new science at major conferences such as EASD. Its core offering remains imaging solutions and imaging trials for drug development, supported by consultancy on study design and disease biology.

Antaros Medical was founded in 2014 in Mölndal, Sweden, by four entrepreneurs who shared extensive backgrounds in science and drug development as well as a commitment to defying convention. Their mission was to use innovative imaging to provide critical, evidence-based decision support for pharmaceutical companies during the clinical development phase. From the outset, the company was conceived not merely as an imaging provider but as a partner that could connect imaging technology with an understanding of disease biology and the realities of drug development. Over the following years, Antaros Medical established itself as a strategic development partner to the pharmaceutical industry. It built a capability set that combined ground-breaking imaging with profound drug-development experience and deep knowledge of disease mechanisms, creating solutions that the company says few others can. This positioning allowed it to advise clients on study design and to deliver clinical imaging studies addressing relevant biology, rather than simply executing imaging tasks. The company's scientific output grew alongside its service business. Its work is associated with over 800 peer-reviewed publications, a figure the company highlights as evidence of its scientific depth. Operationally, Antaros Medical expanded its global footprint in support of clinical trials, reporting more than 400 imaging sites globally. Its team grew from its founding group to over 100 employees, and later to more than 140 people across two continents, drawing staff from different corners of the world with varied experience and knowledge. Antaros Medical continues to present new science at major conferences, including EASD, and to describe itself as a growing team of visionaries. It remains privately held and headquartered in Mölndal, Sweden, focused on imaging solutions and imaging trials for drug development.

• 2026

  New science presented at EASD 2026.

• 2014

  Antaros Medical founded in Mölndal, Sweden, by four entrepreneurs with backgrounds in science and drug development.

• Established as a strategic development partner to the pharmaceutical industry, combining imaging with drug-development and disease-biology expertise.

• Reached over 800 peer-reviewed publications associated with its work.

• Reported more than 400 imaging sites globally and over 100 employees.

• Grew to more than 140 employees across two continents.

A strategic development partner to the pharmaceutical industry, combining ground-breaking medical imaging with deep drug-development and disease-biology expertise to support evidence-based decisions in clinical development.

• Imaging solutions for drug development

  Tailored imaging solutions and imaging trials that provide vital insights around a drug, supporting decision-making in clinical development.

• Clinical imaging trials

  Delivery of clinical imaging studies addressing relevant biology, supported by expertise in study design and disease biology.

• Study-design and disease-biology consultancy

  Advice on study design and drug-development strategy based on imaging capabilities and disease-biology knowledge.

1. 1Imaging the future - Antaros Medicalantarosmedical.com
2. 2About us - Antaros Medicalantarosmedical.com
3. 3Antaros Medical (Sweden) - Wikidatawikidata.org